This compound is primarily studied in research/clinical settings & may not be widely available as a regulated over-the-counter supplement. Information is provided for educational purposes only — not as a recommendation to use. See our Safety page.
Semaglutide
Semaglutide is a GLP-1 receptor agonist used for significant weight loss and glycemic control in individuals with obesity and type 2 diabetes. It is administered as a once-weekly injection and has shown efficacy in reducing body weight by 15-17% in clinical trials.
Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.
Semaglutide resulted in a mean weight reduction of 11.85% compared to placebo.
Semaglutide led to a 14.9% reduction in body weight compared to 2.4% with placebo.
Semaglutide improved glycemic control and reduced body weight in type 2 diabetes patients.
Continued semaglutide use maintained weight loss, but withdrawal led to weight regain.
Semaglutide reduced cardiometabolic risk factors but increased gastrointestinal adverse events.
Stacks containing Semaglutide
Public community stacks that include this ingredient.